# E-DRUG: Table of contents of Prescrire International, August 1998 **URL:** \ **Category:** e-drug\ **Created:** [August 6, 1998, 7:42pm UTC](https://talk.edrugplus.org/t/e-drug-table-of-contents-of-prescrire-international-august-1998/3227 "1998-08-06T19:42:23Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Prescrire\_Internatio](https://avatars.discourse-cdn.com/v4/letter/p/7c8e57/32.png) [@Prescrire\_Internatio](https://talk.edrugplus.org/u/Prescrire_Internatio)\ **Post date:** [August 6, 1998, 7:42pm UTC](https://talk.edrugplus.org/t/e-drug-table-of-contents-of-prescrire-international-august-1998/3227/1 "1998-08-06T19:42:23Z")
E-drug: Table of contents of Prescrire International, August 1998 ---------------------------------------------------------- Table of contents of Prescrire International, August 1998 - Volume 7 � Nr. 36 Prescrire International is the English language edition of La revue Prescrire. It consists of a selection of articles of international interest from the monthly French-language journal La revue Prescrire. Prescrire International contains evaluations of new drugs and new indications, information on adverse effects, and assessments of therapeutic interventions. Editorial New, or just new-fangled? New Products Tiagabine (new preparation) Possibly helpful for multiresistant epileptic patients Cefpodoxime (new dosage) Unproven dose regimen in recurrent pharyngitis Intravenous pamidronic acid (new indications) Useful palliative treatment for osteolysis Clodronic acid (a second look) No value in malignant osteolysis Glimepiride (new preparation) Just another sulphonylurea agent Tacrolimus in the prevention of graft rejection (new indication) Helpful alternative to ciclosporin Fluoride and bone (a second look) No place in primary or secondary prevention of osteoporosis Venlafaxine (new preparation) No advantage over available antidepressants Adverse Effects Severe hypertriglyceridaemia on tamoxifen Does not challenge its positive risk-benefit ratio in breast cancer Meloxicam and gastrointestinal toxicity Cases of potentially severe reactions Anorectic drugs: managing the risk of valve disease Watch out for valve disease in exposed patients Hepatic toxicity of the tiliquinol-tilbroquinol combination An old product with a negative risk-benefit ratio in acute diarrhoea Reviews Cardiovascular risk of oral contraceptives Low, and mainly in women with risk factors Prevention of haemorrhagic disease of the newborn Routine vitamin K1 administration is justified Prescrire International is financed by subscription fees only. We cannot provide free subscriptions. If you do not know the journal we can send you a sample issue. Send us your name and address if you want to receive a sample issue of Prescrire International. An annual subscription covers six issues of Prescrire International plus an index to issues during the previous five years and costs $ 60 (FF 310) for individuals, $38 (FF 200) for students, and 360$ (FF1860) for commercial institutions. Prescrire International Association Mieux Prescrire BP 459 75527 Paris Cedex 11 France Tel. 33 1 47 00 94 45 Fax 33 1 48 07 87 32 email : international@prescrire.org -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.